Pharmacokinetic-Pharmacodynamic Modelling of Ketamine in Six Neurotraumatised Intensive Care Patients

被引：0
|
作者：
Youssef Hijazi
Carole Bodonian
François Salord
Françoise Bressolle
Roselyne Boulieu
机构：
[1] Université Claude Bernard Lyon 1,Faculté de Pharmacie, Département de Pharmacie, Clinique de Pharmacocinétique et d’Evaluation du Médicament
[2] Hôpital Neuro-Cardiologique,Laboratoire de Pharmacocinétique Clinique
[3] Hôpital Neuro-Cardiologique,Service de Soins Intensifs Post
[4] Université de Montpellier I,opératoires
来源：
Clinical Drug Investigation | 2003年 / 23卷
关键词：
Ketamine; Intensive Care Unit Patient; Intensive Care Patient; Sedation Score; Anaesthetic Depth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：605 / 609
页数：4
相关论文
共 50 条
  • [31] Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients
    Mentré, F
    Pousset, F
    Comets, E
    Plaud, B
    Diquet, B
    Montalescot, G
    Ankri, A
    Mallet, A
    Lechat, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (01) : 64 - 78
  • [32] PHARMACOKINETIC-PHARMACODYNAMIC INTERACTIONS OF INTENSIVE CYCLOPHOSPHAMIDE, CISPLATIN, AND BCNU IN PATIENTS WITH BREAST-CANCER
    JONES, RB
    MATTHES, S
    DUFTON, C
    BEARMAN, SI
    STEMMER, SM
    MEYERS, S
    SHAPALL, EJ
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 : S11 - S17
  • [33] Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development
    Dingemanse, Jasper
    Krause, Andreas
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 109 : S53 - S58
  • [34] Pharmacokinetic-Pharmacodynamic Modelling of Biomarker Response to Sitagliptin in Healthy Volunteers
    Kim, Bo-Hyung
    Kim, Sung Eun
    Kang, Dongwoo
    Lim, Kyoung Soo
    Kim, Jung-Ryul
    Jang, In-Jin
    Shin, Sang-Goo
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Yu, Kyung-Sang
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 (02) : 113 - 125
  • [35] Optimising ciprofloxacin dosing in intensive care patients based on pharmacodynamic target attainment through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulation
    Khachman, D.
    Conil, J.
    Georges, B.
    Saivin, S.
    Houin, G.
    Toutain, P.
    Laffont, C.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 2 - 2
  • [36] The pharmacokinetic-pharmacodynamic relationship of ARANESP™ in oncology patients.
    Tseng, L
    Heatherington, A
    Colowik, A
    [J]. BLOOD, 2000, 96 (11) : 156B - 156B
  • [37] Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations
    Khachman, Dalia
    Conil, Jean-Marie
    Georges, Bernard
    Saivin, Sylvie
    Houin, Georges
    Toutain, Pierre-Louis
    Laffont, Celine M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (08) : 1798 - 1809
  • [38] Amikacin Pharmacokinetic-Pharmacodynamic Analysis in Pediatric Cancer Patients
    Alhadab, Ali A.
    Ahmed, Mariam A.
    Brundage, Richard C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [39] Development of a pharmacokinetic-pharmacodynamic model of inolimomab in GVHD patients
    Girard, P.
    Dartois, C.
    Michallet, M.
    Henin, E.
    Vermot-Desroches, C.
    Tranchand, B.
    Trillet-Lenoir, V
    Freyer, G.
    [J]. BULLETIN DU CANCER, 2008, 95 : S74 - S74
  • [40] A Population Pharmacokinetic-Pharmacodynamic Model for Allopurinol in Patients with Gout
    Wright, Daniel F. B.
    Duffull, Stephen B.
    Merriman, Tony R.
    Barclay, Murray L.
    Stamp, Lisa K.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S33 - S33
12345